ELMD Stock Analysis: Buy, Sell, or Hold?
ELMD - Electromed, Inc.
$23.29
-0.36 (-1.52%)
▼
5d:
-4.74%
30d:
-4.12%
90d:
-20.02%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
ELMD is down 4.3% this week, but smart money is accumulating calls. Top strike: $25 2026-04-17 with 10 OI. Call ratio: 100% View Scanner →
Strength: 7.1/10
Get Alerted When ELMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ELMD appears deeply undervalued. Market expects -7.3% annual earnings decline despite 46% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: ELMD appears deeply undervalued. Market expects -7.3% annual earnings decline despite 46% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$51.08
Based on 12.0% avg growth
INTRINSIC VALUE TODAY
$31.72
26.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELMD is currently trading at $23.29, which is considered oversold relative to its 30-day fair value range of $23.47 to $24.41. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.6) compared to its historical average (22.1). Remarkably, the market is currently pricing in an annual earnings decline of 7.3% over the next few years. This pessimistic expectation contrasts with the company's recent 45.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ELMD is in a downtrend. The price is currently testing key support at $23.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.00 (+58.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELMD is in a downtrend. The price is currently testing key support at $23.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.00 (+58.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$23.47 -
$24.41
Company Quality Score
60/100
(BUY)
Options IV Signal
41th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 41th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 58.9% below Wall St target ($37.00)
Fair Price Analysis
30-Day Fair Range
$23.47 -
$24.41
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$2.37
(10.2%)
Support & Resistance Levels
Support Level
$23.03
Resistance Level
$24.99
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.64
Wall Street Target
$37.00
(+58.9%)
Revenue Growth (YoY)
16.3%
Earnings Growth (YoY)
45.5%
Profit Margin
13.1%
Valuation Discount vs History
-7.3% cheaper
PE vs Historical
17.6 vs 22.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.3%
(market-implied from PE analysis)
1-Year Target
$21.59
(-7%)
2-Year Target
$20.01
(-14%)
3-Year Target
$18.55
(-20%)
3-Yr Target (if PE normalizes)
(PE: 18→22)
$23.24
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 20.0%)
$46.92
(+102%)
Base:
(SPY PE: 17.6, Growth: 20.0%)
$40.25
(+73%)
Bear:
(PE: 15.0, Growth: 20.0%)
$34.21
(+47%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 22.60 | Current EPS (TTM): $1.03
Bull Case
$32.82
(+34%)
Analyst growth 28.2%, PE expands to 24.9
Base Case
$29.83
(+22%)
Market implied 28.2%, PE stable at 22.6
Bear Case
$15.83
(-35%)
Severe decline -20.0%, PE contracts to 19.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.6 to 22.1
Stabilization Target:
$29.17
(+25.3%)
PE Expansion Potential:
+25.3%
Share & Embed Analysis
Last updated: April 06, 2026 12:37 AM ET
Data refreshes hourly during market hours. Next update: 1:37 AM
Data refreshes hourly during market hours. Next update: 1:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELMD showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 62 BUY |
|
PEN
Penumbra Inc |
STRONG BUY
18 analysts |
$360 | 58 HOLD |
Advanced ELMD Option Strategies
Professional options setups generated by AI based on today's ELMD price and gamma walls.
